Pterostilbene suppresses oral cancer cell invasion by inhibiting MMP-2 expression. (October 2014)

• Record Type: Journal Article
• Authors: Lin, Chiao-Wen; Chou, Ying-Erh; Chiou, Hui-Ling; Chen, Mu-Kuan; Yang, Wei-En; Hsieh, Ming-Ju; Yang, Shun-Fa
• Is Part Of: Expert opinion on therapeutic targets. Volume 18:Number 10(2014:Oct.)
• Page Start: 1109
• Page End: 1120
• Publication Date: 2014-10
• Subjects: Drugs -- Research -- Periodicals; 615.072
• DOI: 10.1517/14728222.2014.947962
• Languages: English
• ISSNs: 1744-7631

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold> <italic>Objective:</italic> </bold> Polyphenol compounds, present in a wide variety of natural plants, exhibit antioxidant and free radical scavenging ability and induce apoptosis in various cancer cells. However, the effect of pterostilbene on oral cancer cell metastasis has not been clarified.</p> <p> <bold> <italic>Research design and methods:</italic> </bold> The present study aimed to examine the anti-metastatic properties of pterostilbene in human oral squamous cell carcinoma (SCC)-9 cells.</p> <p> <bold> <italic>Results:</italic> </bold> In this study, pterostilbene treatment significantly inhibited migration/invasion capacities of SCC-9 cells <italic>in vitro.</italic> The results of zymography and western blotting revealed that the activities and protein levels of the MMP-2 and urokinase-type plasminogen activator (u-PA) was inhibited by pterostilbene. Western blot analysis also showed that pterostilbene inhibits the phosphorylation of Akt, extracellular signal-regulated kinase 1/2 and p38. Determinations of the mRNA levels, real-time polymerase chain reaction and promoter assays were conducted to evaluate the inhibitory effects of pterostilbene on MMP-2 and u-PA expression in SCC-9 cells. Such inhibitory effects were associated with the upregulation of tissue inhibitor of metalloproteinase-2, plasminogen activator inhibitor-1 and the downregulation of the transcription factors of NF-κB, SP-1 and CREB signaling pathways.</p> <p> <bold> <italic>Conclusions:</italic> </bold> Pterostilbene may have potential use as a chemopreventive agent against oral cancer metastasis.</p> </abstract>